Board Performance · 2025
In this section13 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Evaluation of Board & Subcommittee Performance3 items
- Subcommittees1 item
- Meeting Attendance & Remuneration2 items
- Supervision of Subsidiaries & Associated Companies5 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Company has established conflicts of interest policy in the Company's Code of Conduct. The Company has the policy to prohibit directors, executives, and employees of all levels from seeking personal benefits that may conflict with the Company's interests or major transactions such as connected transactions and/or acquisition or disposition of the Company's assets by establishing policies and regulations. The processes for considering and approving items or transactions must be in accordance with the internal control system for connected transactions, as well as the requirements of the agencies that govern the listed companies and related laws.
In addition, the directors, executives, and employees must not personally receive any money or compensation from the customers, the Company's business partners or from any person due to working on behalf of the Company and prohibited from doing business or participating in any business that competes with the business of the Group whether or not such executives or employees will benefit directly or indirectly.
If intending to do business with the Company in the name of a person, family or juristic person in which directors, executives and employees have an interest, such interests must be disclosed to the Company before entering into the transaction every time. In this regard, it must be done correctly and in accordance with the rules of the Office of the Securities and Exchange Commission and the Stock Exchange of Thailand and such persons must not be involved in the proceedings and decision-making, directly or indirectly. The Company has disclosed “Business Ethics” on the Company's website.
The Company has communicated its policy on conflict-interest prevention to the 13 board of directors, executives, and employees through various channels, such as training on the first day of orientation for new employees, the organization's central information source, employee group chats within the organization, and also disseminated practices for preventing internal data usage to employees and external personnel via the Company's website. In addition, regular reviews are conducted at board meetings every year.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
Regarding the Company’s internal operations, the Company Secretary is responsible for notifying the Board of Directors, the 13 members of Management, and employees with access to inside information of the "Blackout Period." This period requests cooperation in refraining from trading Company securities for one month prior to the Board of Directors' meetings held to consider the quarterly financial statements. The Company Secretary issues this notification via email at least one month before the start of the restricted trading period to prevent any misuse of inside information.
Furthermore, the Company Secretary has informed the Board of Directors of the following guidelines regarding the trading of Company shares by Directors and Executives:
Directors and Executives are required to notify the Company Secretary of any intended trade of Company securities at least one business day prior to the transaction.
Directors and Executives must prepare and disclose reports of their securities holdings (Form 59) and report any changes in such holdings following every purchase, sale, transfer, or acceptance of transfer. These reports must be submitted to the Office of the Securities and Exchange Commission (SEC) within three business days from the transaction date.
Additionally, the Company Secretary provides a summary report of the securities holdings and any changes therein for Directors and Executives to the Board of Directors during each quarterly meeting held to consider financial performance.
In the past year, the Company found no instances of the aforementioned individuals trading securities using material inside information obtained through their duties which had not yet been disclosed to the public. There were no recorded cases of seeking benefits for themselves or others, whether directly or indirectly.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company has conducted an assessment of corruption-related risks as part of its Risk Management Policy. The Risk Management Committee recognizes the significance and potential impact of corruption risks and ensures that such risks are rigorously assessed and managed.
In 2025, the Company reviewed its Corporate Governance Policy, as well as related policies, including the Anti-Corruption Policy. These policies were communicated to all employees through various channels, such as the Company’s central information system, internal communication platforms, and the Company’s website, to ensure awareness among both employees and external stakeholders.
In addition, The Company organized anti-corruption training programs for employees at all levels through electronic media. The training aimed to enhance knowledge and understanding of the Anti-Corruption Policy, including examples of behaviors that may unintentionally constitute corruption. The Company also conducted related risk assessments, established control and preventive measures, and regularly monitored implementation.
The results of these activities are reported to the Risk Management Committee and the Board of Directors to ensure continuous review and improvement of relevant policies.
In 2025, no complaints or violations related to breaches of the Company’s Anti-Corruption Policy were reported.
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of appropriateness in anti-corruption |
| Assessment and identification of corruption risk |
| Communication and training for employees on anti-corruption policy and guidelines |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The Company has established the Whistleblowing and Complaints Procedure as a framework for receiving complaints and reports of misconduct or corruption, conducting investigations, and ensuring appropriate reporting. The procedure also includes measures to protect whistleblowers who report in good faith. This mechanism provides all stakeholders with the opportunity to submit inquiries, complaints, or reports of suspected misconduct through the channels designated by the Company. This includes cases such as non-compliance with the Code of Conduct, corruption, violations of laws, or breaches of the Company’s policies.
In addition, the Company has disclosed contact channels for complaints and whistleblowing on its website. Reports may also be submitted through the online channels provided.
Channels for Complaints
If any person has concerns or becomes aware of any actions that may constitute misconduct or corruption, they may submit a complaint or report to the Company via email at whistleblowingandcomplaints@winnergy.co.th.To ensure maximum confidentiality, access to this information is restricted to a single authorized person responsible for the secure handling of all details.
Protection of Whistleblowers / Complainants
Whistleblowers and complainants will be provided with appropriate protection. All related information will be treated as strictly confidential, except where disclosure is required by relevant authorities or applicable laws.
The Company also ensures fairness and protection for employees who report concerns or provide information in good faith.
All complaints and reports received will be kept confidential. The Company will promptly conduct an investigation and determine appropriate corrective actions. The results will be reported to the Audit Committee and the Board of Directors, respectively.
Statistics of Complaints and Whistleblowing Reports in 2025
In 2025, the Company did not receive any complaints or whistleblowing reports regarding misconduct or corruption. This includes violations related to insider trading, conflicts of interest, protection of customer confidential information, and breaches of the Company’s ethics and Code of Conduct. Furthermore, there were no cases in which the Company was accused or subject to legal action for human rights violations.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
2
Rights of Minority Shareholders on Director Appointment
Regarding the rights of minority shareholders to appoint directors, the Company’s Articles of Association stipulate that shareholders shall exercise their authority to appoint directors through the shareholders’ meeting. The key details are summarized as follows:
1. Each shareholder shall have one (1) vote per share.
2. In the election of directors, voting may be conducted on an individual basis, electing one director at a time, or several directors as a slate in a single vote for the total number of directors to be elected at that time, as the shareholders’ meeting may deem appropriate. In each voting, each shareholder must cast all the votes to which they are entitled under (1) to elect one person or several persons as a group as directors but may not allocate their votes among any person or group in any proportion.
3. The persons receiving the highest number of votes in descending order shall be elected as directors equal to the number of directors required or to be elected at that meeting. In the event that candidates receiving votes in the subsequent order have equal votes exceeding the number of directors to be appointed or elected at that time, the Chairman of the meeting shall have the casting vote.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
Pursuant to the Corporate Governance Policy and the Charter of the Board of Directors, the Company is required to have independent directors representing at least one-third (1/3) of the total number of directors, and in any case not fewer than three (3) persons, in order to ensure appropriate checks and balances within the Board.
In addition, all independent directors must possess the knowledge, capabilities, and independence qualifications as prescribed by law. They must be able to express their opinions independently at Board meetings, attend meetings regularly, and have sufficient access to financial and other relevant business information to enable them to provide independent views, safeguard the interests of stakeholders, and prevent conflicts of interest between the Company and its management, directors, major shareholders, or other companies with common directors, executives, or major shareholders.
Independent directors are required to certify their independence upon appointment and annually thereafter for disclosure in the Company’s Annual Report, and must notify the Company of any changes thereto.
The Company has established the following qualifications for independent directors:
Holding shares of not more than one percent (1%) of the total voting shares of the Company (including its parent company, subsidiaries, associates, major shareholders, or controlling persons), including shares held by related persons of such independent director.
Not being or having been an executive director, employee, staff member, salaried advisor, or controlling person of the Company (including its parent company, subsidiaries, associates, major shareholders, or controlling persons), unless at least two (2) years have passed since ceasing to have such characteristics.
Not being a person related by blood or legal registration to another director, executive, major shareholder, controlling person, or a person nominated to be a director, executive, or controlling person of the Company or its subsidiary.
Not having or having had any business relationship with the Company (including its parent company, subsidiaries, associates, major shareholders, or controlling persons) in a manner that may interfere with the exercise of independent judgment, and not being or having been a significant shareholder or controlling person of an entity having a business relationship with the Company, unless at least two (2) years have passed since ceasing to have such characteristics.
Not being or having been an auditor of the Company (including its parent company, subsidiaries, associates, major shareholders, or controlling persons), and not being a significant shareholder, controlling person, or partner of an audit firm that audits the Company, unless at least two (2) years have passed since ceasing to have such characteristics.
Not being or having been any professional service provider, including legal or financial advisor, receiving service fees exceeding Baht 2 million per year from the Company, and not being a significant shareholder, controlling person, or partner of such professional service provider, unless at least two (2) years have passed since ceasing to have such characteristics.
Not being a director appointed to represent a director of the Company, a major shareholder, or a shareholder who is related to a major shareholder.
Not conducting any business of the same nature and in significant competition with the business of the Company or its subsidiaries, nor being a significant partner in a partnership, or an executive director, employee, staff member, salaried advisor, or holding more than one percent (1%) of the total voting shares of another company engaging in the same nature of business and in significant competition with the Company or its subsidiaries.
Not having any other characteristics that may impair the ability to express independent opinions regarding the Company’s operations.
Did Any Independent Director Have a Business or Professional Relationship?
No
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
Performance evaluation of the board of directors and subcommittees:
The Company will conduct an annual performance evaluation of the board of directors and subcommittees. The evaluation will be divided into two categories according to the evaluation form of the Thai Institute of Directors (IOD), as follows:
1. Self-evaluation form for the Board of Directors and subcommittees, by committee.
2. Self-evaluation form for the Board of Directors and subcommittees, by individual.
Process for evaluating the performance of the Board of Directors and subcommittees
1. The Nomination and Remuneration Committee will consider and establish policies and criteria for evaluating each main topic in the evaluation form.
2. The Corporate Secretary will distribute the evaluation forms for the Board of Directors and subcommittees to assess their annual performance, both by committee and by individual.
3. All directors will return the evaluation forms to the Corporate Secretary for collection and summary of results. The report will be presented to the Nomination and Remuneration Committee and the Board of Directors at the first meeting of the following year.
Scoring criteria are as follows:
Points received (percentage) | Criteria |
85 - 100 | Excellent |
75 - 84 | Very good |
65 - 74 | Good |
50 - 64 | Decent |
Lower than 50 | Needs Improvement |
Evaluation of Board Performance in the Past Year
The Board of Directors conducts an annual performance evaluation of the directors, comprising both a collective assessment of the Board, individual assessments of each director, and evaluations of the sub-committees. The Nomination and Remuneration Committee has been assigned to establish the evaluation criteria and to oversee the performance evaluation process.
Summary of performance appraisal of the Board of Directors in 2025:
Assessment Results | Score (Percentage) |
Assessment of the performance of the Board of Directors (as a group) | 96.16 |
Evaluation of the performance of the Board of Directors (individual) | 95.39 |
Summary of the performance evaluation of sub-committees in 2024 are as follows:
Assessment Results | Score (Percentage) |
Evaluation of the performance of the Audit Committee (as a group) | 90.00 |
Evaluation of the performance of the Nomination and Remuneration Committee (as a group) | 97.22 |
Evaluation of the performance of the Good Corporate Governance and Sustainability Committee (as a group) | 94.44 |
Evaluation of the performance of the Risk Management Committee (as a group) | 95.00 |
Evaluation of the performance of the Executive Committee (as a group) | 96.47 |
In this regard, the Secretary of the Company will calculate and summarize the performance evaluation results of the Board of Directors and each subcommittee and report the evaluation results to the Board of Directors for acknowledgment annually.
Evaluation Results
| Evaluated Body | Group — Carried Out? | Group — Grade / Average Score | Group — Grade / Full Score | Individual (Self-Assessment) — Carried Out? | Individual (Self-Assessment) — Grade / Average Score | Individual (Self-Assessment) — Grade / Full Score | Cross (Assessing Other Directors) — Carried Out? |
|---|---|---|---|---|---|---|---|
| Board Of Director | Y | 96.16 | 100 | Y | 95.39 | 100 | N |
| Audit Committee | Y | 90.00 | 100 | N | N | ||
| Other Subcommittee | Y | 97.22 | 100 | N | N | ||
| Other Subcommittee | Y | 94.44 | 100 | N | N | ||
| Other Subcommittee | Y | 95 | 100 | N | N | ||
| Executive Committee | Y | 96.47 | 100 | N | N |
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Nomination and Remuneration Committee consisted of three members, with the following individuals: 1. Asst. Prof. Dr. Terdsak Rojsurakitti Chairman of the Nomination and Remuneration Committee 2. Dr. Renu Ubol Member of the Nomination and Remuneration Committee 3. Mr. Nanthiya Darakananda Member of the Nomination and Remuneration Committee The Nomination and Remuneration Committee has duties and responsibilities in accordance with the Nomination and Remuneration Committee Charter regarding the establishment of policies, criteria, and procedures for the nomination of directors, sub-committee members, the Chief Executive Officer, and senior executives. This includes considering the appropriateness of the number, structure, and composition of the Board of Directors, the Chief Executive Officer, and senior executives, as well as overseeing the preparation of a succession plan for the Chief Executive Officer and senior executives. The Committee is also responsible for considering and establishing policies on the determination of remuneration rates and other benefits for directors, for submission to the Board of Directors’ meeting for consideration and approval. In 2025, the Nomination and Remuneration Committee convened a total of two (2) meetings, with all members attending each meeting. The Nomination and Remuneration Committee performed its duties in accordance with the scope of authority, duties, and responsibilities as stipulated in its Charter. A summary of the key matters considered and the opinions of the Nomination and Remuneration Committee in 2025 is as follows: 1. Considered and endorsed the appointment of directors to replace those retiring by rotation. 2. Evaluated the performance of the Board of Directors, its sub-committees, and the Chief Executive Officer. To ensure that the Company’s governance, control, and management processes are conducted in accordance with good corporate governance principles, and to monitor and assess performance against established objectives and targets, the Company has established a practice whereby the Board of Directors, its sub-committees, and the Chief Executive Officer are required to undergo a performance evaluation at least once a year. The evaluation results serve as information for the Board of Directors, its sub-committees, and the Chief Executive Officer to review their performance, as well as issues and obstacles encountered during the year. 3. Considered the remuneration of the Board of Directors and the sub-committees. The Company has established a transparent process for determining the remuneration and other benefits of the Board of Directors and the sub-committees, in accordance with good corporate governance principles and aligned with the Company’s strategy and long-term objectives. The components of remuneration and other benefits are appropriately structured and sufficient to attract and retain qualified individuals. In determining such remuneration, the Company has taken into consideration the Directors’ Remuneration Survey Report 2024 conducted by the Thai Institute of Directors (IOD). The details are as follows: 3.1 Remuneration and other benefits determination process The nominating and compensation committee is responsible for considering and determining the compensation and other benefits of the board of directors and its subcommittees, which are then proposed to the board of directors for approval within the framework authorized by the shareholders' meeting. 3.2 Guidelines for determination of remuneration and other benefits The Nomination and Remuneration Committee will consider the remuneration of the Board of Directors and its subcommittees, to ensure that the remuneration is appropriate, by comparing it with the remuneration of companies in the same industry, as well as taking into account the duties, responsibilities, and performance of the directors to motivate and retain qualified personnel. The proposed remuneration will be presented to the company's Board of Directors and the Shareholders' Meeting for approval.
Remark: 1. “Other sub-committees" refers to the Nomination and Remuneration Committee, Risk Management Committee, and Management Committee. 2. Directors who are executives, employees of the company, and representatives of major shareholders are not entitled to compensation as directors or members of subcommittees. The number of directors who are not entitled to such compensation is 6, as follows: (1) Mr. Amarin Pataranavig is a representative of the major shareholder (Mr. Sumeth Darakananda) (2) Mr. Tanakorn Vidhayasirinun Representing a major shareholder (Mr. Sumeth Darakananda) (3) Mr. Nanthiya Darakananda is an executive who is an employee of the company and representative of major shareholders (Mr. Sumeth Darakananda) (4) D.D.S. Jinhatha Panyasorn is a consultant who is an employee of the Company. (5) Mr. Rachan Arayawongchai is an executive who is an employee of the company. (6) Mr. Kamol Sakulworapatsiri is an executive who is an employee of the company.
In this regard, such remuneration has been approved by the Annual General Meeting of Shareholders for the year 2025 on April 24, 2025. 4. Review of the Charter of the Nomination and Remuneration Committee The meeting of the Nomination and Remuneration Committee considered the review of the Charter of the Nomination and Remuneration Committee for the year 2025. The Nomination and Remuneration Committee was of the opinion that the current Charter of the Nomination and Remuneration Committee remains appropriate for the Company’s business context and is consistent with the principles of good corporate governance. Therefore, it was deemed appropriate to continue using the current charter without any significant amendments. | ||||||||||||||||||||
Recognizing the importance of enterprise risk management, the Board of Directors of Winnergy Medical Public Company Limited has appointed the Risk Management Committee to establish policies, objectives, and a framework for enterprise risk management covering all aspects. This is to reduce or control the impact of various risk factors, both external and internal, on the Company’s business operations to an acceptable or manageable level. The Committee also oversees the implementation of an effective risk management process and promotes its development as part of the organizational culture by integrating it into the Company’s strategic plans and operational plans. This is to ensure that the Company can achieve its objectives in accordance with its sustainable growth plan and create long-term value for shareholders. The Board of Directors assigns responsibilities to the Risk Management Committee as specified in its charter, with a scope consistent with good corporate governance practices and the corporate governance principles prescribed by the Securities and Exchange Commission. These responsibilities include identifying risks that may affect the Company’s business operations, assessing the likelihood and impact of such risks, overseeing the establishment of risk control or mitigation plans, and providing recommendations to ensure that such plans are sufficiently effective. The Committee also reviews risk management plans, monitors the progress of the management in implementing the risk management plans, and provides advice and recommendations regarding risk management operations. At present, the Risk Management Committee consists of three members who are senior executives with the knowledge, capabilities, experience, and qualifications as prescribed in the Charter of the Risk Management Committee, as follows: 1. Mr. Nanthiya Darakananda Chairman of the Risk Management Committee 2. Mr. Rachan Arayawongchai Member of the Risk Management Committee 3. Mr. Tanakorn Vidhayasirinun Member of the Risk Management Committee In 2025, the Risk Management Committee held a total of three meetings to perform its duties as assigned by the Board of Directors and reported the results of its operations to the Board of Directors for acknowledgment. The key duties performed and the opinions of the Risk Management Committee in 2025 are summarized as follows: 1. Reviewed the Charter of the Risk Management Committee before proposing it to the Board of Directors for approval and implementation within the Company. The Charter serves as a guideline for the duties, operations, and responsibilities of the Risk Management Committee in overseeing risk governance, risk management, and the control and mitigation of risks that may impact the Company’s business, as assigned by the Board of Directors, and to ensure alignment with good corporate governance practices. 2. Reviewed the Company’s overall risk management and risk governance by considering the appropriateness and effectiveness of the management’s risk management in relation to identified risks that significantly impact the Company’s business. This is to ensure that adequate and appropriate control or mitigation measures are established. The Committee monitored risk management activities under the Company’s “Risk Management Policy,” which forms part of the Company’s business strategy and operations, and provided additional recommendations to enhance efficiency and effectiveness. The scope covered strategic, operational, financial, compliance, social and environmental aspects, as well as emerging risks, including the monitoring and management of such risks, the adequacy and effectiveness of the risk management system, and the performance of other duties as stipulated in the Charter of the Risk Management Committee. 3. Monitored the progress of information security and information system protection measures and acknowledged the current global and industry cyber threat landscape, including the Company’s risk management measures. These were presented by the responsible risk owners, and the Committee provided comments to strengthen protection against potential damages from cybercrime. 4. Considered and reviewed management’s risk management measures in response to the volatility of foreign exchange rates, as the Company has both revenues and expenses in foreign currencies. The Committee provided comments and recommendations to reduce potential impacts through risk diversification and the management of foreign currency revenues and expenses in major currencies to ensure appropriate alignment. 5. Reviewed the results of campaigns on workplace safety and social and environmental responsibility. The Committee provided recommendations to management to improve plans and analyses aimed at reducing workplace accidents and progressively strengthening the Company’s safety culture. 6. Supported the promotion of a Risk and Control Culture within the organization by acknowledging plans and results of related activities in collaboration with the Audit Committee. The Committee also provided comments and recommendations to enhance processes in accordance with the Three Lines Model. 7. Reviewed the risk management structure, including the appointment of the Secretary of the Risk Management Committee and the Risk Management Working Team. Directors and executives at all levels play roles and participate in developing the Company’s risk management system, assisting in assessing, controlling, and monitoring risks across each business unit to ensure confidence in the risk management process and the effectiveness of the organization. 8. Evaluated the performance of the Risk Management Committee for the year 2025 in accordance with the guidelines of the Stock Exchange of Thailand. The evaluation results indicated that the Risk Management Committee performed its duties and responsibilities as stipulated in the Charter of the Risk Management Committee. The Committee assures shareholders of its commitment to supporting the Board of Directors in driving the Company’s progress toward sustainable growth through adequate and appropriate risk management oversight. In summary, the Risk Management Committee performed its assigned duties effectively, taking into consideration economic conditions and revenue growth with prudence in order to create value and benefits for shareholders and stakeholders. The Committee regularly reported the results of its performance to the Board of Directors each year. In addition, the Committee conducted a performance evaluation for 2025 to ensure that its operations were effective and in line with good corporate governance principles. The self-assessment form of the Risk Management Committee, adapted from the template of the Thai Institute of Directors Association, was applied, and the evaluation result was rated at the “Very Good” level. | ||||||||||||||||||||
The Corporate Governance and Sustainability Committee consisted of three members, with the following individuals: 1. Asst. Prof. Dr. Terdsak Rojsurakitti Chairman of the Corporate Governance and Sustainability Committee 2. Dr. Renu Ubol Member of the Corporate Governance and Sustainability Committee 3. Mr. Nanthiya Darakananda Member of the Corporate Governance and Sustainability Committee In 2025, the Corporate Governance and Sustainability Committee convened a total of one (1) meetings, with all members attending each meeting. The Corporate Governance and Sustainability Committee performed its duties in accordance with the scope of authority, duties, and responsibilities as stipulated in its Charter. A summary of the key matters considered and the opinions of the Corporate Governance and Sustainability Committee in 2025 is as follows: 1. Acknowledged the report of the Corporate Governance and Sustainability Committee. 2. Reviewed the Charter of the Board of Directors and the sub-committees for the year 2025. 3. Considered and approved the Company’s sustainability plans and activities. | ||||||||||||||||||||
Meeting Attendance & Remuneration
Types of Remuneration of the Board of Directors
The Company has clearly set a framework and the director’s remuneration policy at an appropriate level to the duties and responsibilities, and in accordance with the remuneration of companies in the same industry and of similar size. Improvement will be made when changes occur. The remuneration must be suitable and sufficient to motivate and retain qualified directors. Nomination and Remuneration Committee membership will annually consider and propose the Director’s remuneration to the Board of Directors’ meeting and the shareholders’ meeting to consider and approve.
Policy on Directors' Remuneration
The Company specifies that the remuneration of the Board of Directors and its subcommittees must be appropriate, taking into consideration the remuneration of companies in the same industry and those of similar size. Additionally, the remuneration should be suitable for the duties, responsibilities, and performance of the directors in order to motivate and retain high-quality personnel.
The Company does not have a policy of providing remuneration in any other form of currency besides meeting allowances.
However, executives, advisors, employees, or representatives of major shareholders are not entitled to receive remuneration as board members or subcommittee members.
Nonetheless, directors who are employees or staff of the Company are entitled to allowances and benefits that are provided to employees or staff of the company, according to the company's regulations. The remuneration received by directors as board members will not affect their rights to receive the aforementioned allowances and benefits as employees or staff of the Company.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The mechanism for supervising and overseeing the management and operational responsibility of subsidiary and joint venture companies is approved by the Board of Directors. The Board of Directors sets the mechanism for supervising and overseeing the operations of subsidiary and joint venture companies to preserve the benefits of the Company's investment, as follows:
1. The Company will send "representatives" who possess qualifications and experience suitable for the businesses and operations of the companies they invest in. To become a director in such companies, they must be considered and approved at a board of directors meeting.
2. The "representatives" of the Company may hold positions such as chairman, CEO, board member, senior executive, or any person in the company who does not conflict with the business interests of these companies. This is to allow the Company to oversee and manage the operations of each company as if they were their own units, as well as to ensure that all operations comply with laws, regulations, and policies of the companies.
3. Sending "representatives" to become directors in the companies they invest in will be based on the proportion of shareholding in each company and/or mutual agreement in the case of joint ventures, which determines the number of directors to control and oversee.
4. The Company will establish plans and take necessary actions to ensure that each company they invest in has sufficient disclosure of information and internal control systems suitable for their business operations.
5. The Company will closely monitor the performance and operations of each company they invest in, including data collection and accounting record keeping, to allow for easy verification.
6. The Company monitors the disclosure of information regarding its financial position and operational performance, transactions of subsidiaries, related-party transactions, as well as the acquisition or disposal of significant assets. The Company ensures that all material information is disclosed to the Company accurately, completely, and in a timely manner.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Other important transactions |
| Acquisition or disposal of assets |
| Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business |
Agreements Between the Company and Shareholders in Managing Subsidiaries
-None-
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In 2025, the Board of Directors considered significant matters covering corporate governance compliance, risk management and internal audit, corporate strategy, as well as other opinions beneficial to the Company’s business development. The details are summarized as follows:
Consideration of the Company’s Annual Financial Statements and Business Plan
The Board of Directors considered the annual budget and business plan and provided useful recommendations to the management to ensure that the Company’s budget utilization and implementation of the business plan are carried out efficiently for the utmost benefit of the Company and its shareholders.
Approval of the Annual Budget for 2025 of the Company and Its Subsidiaries
Consideration of the Date, Time, Agenda, and Record Date for Determining the List of Shareholders Entitled to Attend the 2025 Annual General Meeting of Shareholders
The Board of Directors considered and approved the date, time, agenda, and the Record Date for determining the list of shareholders entitled to attend the 2025 Annual General Meeting of Shareholders.
Consideration of the Report on Shareholdings and Changes in Securities Holdings of Directors and Executives
The Board of Directors assigned the Company Secretary to clarify the guidelines on securities trading by directors and executives, as well as to report the shareholdings and changes in securities holdings of directors and executives on a quarterly basis, in compliance with good corporate governance principles and to prevent directors and executives from trading the Company’s securities during the blackout period prior to the disclosure of the quarterly and annual financial statements or other financial information to the public.
Consideration of the Performance Evaluation Results of the Board of Directors and Subcommittees
The Board of Directors acknowledged the annual performance evaluation results of the Board, both on a collective and individual basis, including the evaluation results of all subcommittees for the year 2024, as well as the action plans to enhance the effectiveness of the Board and its subcommittees.
Consideration of the Performance Report of the Board of Directors and Subcommittees for the Year 2024
The Board of Directors acknowledged the report on the significant performance of the Board of Directors and its subcommittees for the year 2024.
Consideration of the meeting schedule of the Board of Directors for the year 2026
The Board of Directors considered and approved the meeting schedule for the year 2026 to enable all directors to allocate time and attend meetings in accordance with good corporate governance principles. The meetings are scheduled to be held within 45 days from the end of each accounting period.
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
The Audit Committee of Winnergy Medical Public Company Limited is appointed by the Board of Directors and comprises three independent directors. Each member is a qualified professional with extensive experience and meets all requirements for independence as stipulated in the Audit Committee Charter, in alignment with the best practices of the Office of the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET). The members are as follows:
Mr. Chanat Sorakraikitikul – Chairman of the Audit Committee
Dr. Renu Ubol – Member of the Audit Committee
Mr. Nattaphol Vimolchalao – Member of the Audit Committee
In 2025, the Audit Committee held a total of five meetings with the Head of Internal Audit, External Auditors, and relevant senior management. Additionally, one private meeting was held exclusively with the External and Internal Auditors, without management present, to ensure independent performance of duties. The Committee focused on promoting transparency, sustainable growth, and the balanced interests of all stakeholders. The summary of significant activities is as follows:
1. Review of Financial Reports
The Committee reviewed the quarterly and annual 2025 financial statements, including consolidated and separate financial reports, alongside the external auditors and financial management. This review ensured that the statements were prepared accurately, completely, and contained adequate disclosures regarding significant accounting adjustments, estimates, and auditor independence. The Committee concluded that the financial reports were prepared in accordance with Generally Accepted Accounting Principles (GAAP) and Financial Reporting Standards, providing reliable and timely information for users.
2. Review of Related Party Transactions
The Committee reviewed transactions between related parties or those that may pose a conflict of interest, ensuring compliance with SEC and SET regulations. The review confirmed that all such transactions were conducted under general commercial terms, were reasonable, and served the best interests of the Group.
3. Review of Internal Control Effectiveness
The Committee prioritized the adequacy and effectiveness of internal control systems by evaluating reports based on a risk-based audit approach. Following the review of the external auditor’s observations—which found no material deficiencies regarding financial reporting or internal controls—the Committee consistently monitored management's progress on improvements.
4. Corporate Governance and Legal Compliance
In 2025, the Committee emphasized systematic good governance and promoted the use of Information Technology (IT) in auditing to increase efficiency and prevent misconduct. The Committee reviewed compliance with Securities and Exchange laws and other business-related regulations. Furthermore, the Whistleblowing process was reviewed to ensure fairness for all parties, with appropriate protection for both complainants and the accused.
5. Oversight of Internal Audit
The Committee approved the 2025 Annual Internal Audit Plan based on a risk-based approach. We assessed the independence and adequacy of internal audit resources and provided recommendations for engaging external specialists to audit specific internal systems. The Internal Audit and Audit Committee Charters were also reviewed to ensure they remain aligned with current SET requirements.
6. Appointment of External Auditors for 2025
Based on independence, skills, and experience, the Audit Committee proposed the appointment of the following auditors (or any one of them):
Mr. Vichai Rujitanon (CPA No. 4054) OR
Ms. Kulthida Phasuraku (CPA No. 5946) OR
Mr. Yutthapong Cheumuangphan (CPA No. 9445) OR
Ms. Atchara Suknaibaibun (CPA No. 4642) OR
Ms. Patcharee Sirisongsilp (CPA No. 9037)
7. Quality Assurance of the Audit Committee
The Committee performed a self-assessment for 2025 based on the SEC’s evaluation forms, achieving a "Very Good" rating. Performance results and observations regarding risk management and internal controls were reported to the Board of Directors on a quarterly basis. The Audit Committee has performed its duties with due care, integrity, and independence. It is our opinion that the Company’s financial reports are accurate, reliable, and compliant with accounting standards. The Company maintains effective internal controls, adequate risk management, and a robust corporate governance framework that aligns with all legal and regulatory obligations.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
The Executive Committee consisted of three members, with the following individuals:
1. Mr. Nanthiya Darakananda Chairman of the Executive Board
2. Mr. Rachan Arayawongchai Executive committee
3. Mr. Kamol Sakulworapatsiri Executive committee
The Executive Committee has duties and responsibilities in accordance with the Executive Committee Charter, which include but are not limited to determining the direction of business operations, as well as the development and expansion of the business in line with the Company’s vision, mission, objectives, goals, strategies, approaches, policies, business plans, budget, and organizational structure. This also includes the consideration and approval of operations that constitute transactions in the ordinary course of the Company’s business in accordance with the investment budget or budget approved by the Board of Directors. The approval limit for each transaction shall be in accordance with the Company’s Authorization Manual as approved by the Board of Directors’ meeting, but shall not exceed the annual budget approved by the Board of Directors, including the execution of contracts related to such matters.
In 2025, the Executive Committee convened a total of three (3) meetings, with all members attending each meeting. The Executive Committee performed its duties in accordance with the scope of authority, duties, and responsibilities as stipulated in its Charter. A summary of the key matters considered and the opinions of the Executive Committee in 2025 is as follows:
1. Considered and approved various transactions of the Company, such as short-term credit facilities and long-term loan facilities, within the authority framework delegated by the Board of Directors.
2. Considered and approved the lease of warehouse building space by a subsidiary for the establishment of a medical technology clinic.
3. Considered and approved the reallocation of the annual budget for 2025, in accordance with the Company’s Authorization Manual.
4. Considered and approved the acquisition of land for use as an office building and warehouse expansion.
5. Considered and approved the disposal of assets that have reached the end of their useful life.
6. Reviewed the policy on incentive payments from the sale of products or goods in the medical business group, as well as the criteria for consideration of incentive payments for service technicians.

